TRPC7 and familial pancreatic carcinoma: Our study confirmed that ZINC000001612996, ZINC000052955754, ZINC000003978005, and ZINC000006716957 might be small molecule drugs acting as co-ligands of TRPC3 and TRPC7 by the molecular docking technique, and this result suggests that these four small molecule drugs have potential as targeted therapeutic agents for pancreatic cancer.